Vitafoods Insights is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Ashwagandha Chronicles

Return to natural plant medicine with ashwagandha [Report]

White-paper-Return to natural plant medicine with ashwagandha [Report]

Return to natural plant medicine with ashwagandha [Report]
As E.U. consumers take an increasingly proactive approach to health and wellness, this ancient adaptogen is more relevant than ever before.

In the United States, ashwagandha has become the go-to adaptogen for consumers seeking natural wellness solutions. It’s the central ingredient in cookies and smoothies, a star player in sports and brain health supplements. In Europe, adaptogens like ashwagandha are just gaining momentum, pointing to huge market opportunity.

In this special report, we take a deep dive into innovations and opportunities surrounding this adaptogenic all-star in the European market. 

You’ll find:

  • The latest scientific evidence supporting ashwagandha’s benefits.
  • How ashwagandha’s success in the U.S. market can inform European strategies to support its growth.
  • Why a focus on sustainability will be key to increased adoption throughout Europe.